Shield Therapeutics plc Capital Reinvestment Ratio

Latest as of June 2020: 0.00x

Shield Therapeutics plc capital reinvestment ratio. Shield Therapeutics plc (STX) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow (GBX2.40 Million) in capital expenditures (GBX2.00K). Check Shield Therapeutics plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

GBX2.40 Million

GBX

Capital Expenditures

GBX2.00K

GBX

Data as of

Jun 2020

Most recent filing

Shield Therapeutics plc Capital Reinvestment Ratio by Year (None–None)

Shield Therapeutics plc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Shield Therapeutics plc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow